In a computational simulation of human heart cells, researchers found that selective beta-1 adrenergic receptor block increases susceptibility to cardiac arrhythmias in long QT syndrome type 3, whereas full beta-2 receptor block reduces this vulnerability. The findings emerge from an in silico population investigation published in Frontiers in Physiology that investigated the underlying mechanisms of selective beta-receptor block using a population-based computational approach.

Long QT syndrome type 3, or LQT3, is caused by a gain-of-function mutation in the voltage-gated sodium channel Nav1.5. This genetic alteration produces an elevated late sodium current, known as INaL, which prolongs the cardiac action potential duration and promotes early afterdepolarizations that can trigger fatal arrhythmias. Although clinical management of LQT3 frequently involves beta-adrenergic receptor blockers, recent clinical studies indicate that these medications may not provide therapeutic benefits, possibly contributing to an elevated risk of mortality during cardiac events relative to other long QT subtypes.

To elucidate why conventional beta-blockade may fail or cause harm, investigators Andrea S. Castelblanco Agostini, Jacob A. Miller, and Seth H. Weinberg developed a population-based computational model. The researchers simulated 983 virtual human ventricular myocytes with augmented INaL to mimic the electrophysiological hallmarks of LQT3. This virtual cohort enabled detailed evaluation of electrophysiological behavior and beta-adrenergic signaling dynamics across varying degrees of selective beta-1 and beta-2 receptor inhibition.

The computational framework quantified each virtual cell’s susceptibility to arrhythmic events by tracking the prolongation of action potential duration and the emergence of early afterdepolarizations. Using these criteria, the authors separated the simulated myocytes into susceptible and non-susceptible subpopulations, allowing direct comparative analyses of susceptibility pathways, protein phosphorylation states, and individual ionic current conductances.

The model revealed sharply divergent outcomes between the two receptor subtypes. Blocking beta-1 receptors increased arrhythmia susceptibility across the simulated myocytes, an adverse effect driven primarily by reduced phosphorylation of the slow delayed rectifier potassium current, IKs. Conversely, complete beta-2 receptor blockade reduced susceptibility by diminishing the phosphorylation of the L-type calcium current, ICaL. Notably, partial beta-2 receptor blockade failed to confer this protective benefit.

Analysis of ionic current conductances across the susceptible and non-susceptible cohorts demonstrated that beta-blocker exposure drove critical imbalances between inward depolarizing currents and outward repolarizing currents. The authors conclude that these findings motivate the development and preclinical testing of more selective beta-2-blocking agents, which could improve therapeutic outcomes in LQT3 patients.

Subject of Research: Differential electrophysiological effects of beta-1 and beta-2 adrenergic receptor blockade in long QT syndrome type 3

Article Title: Differential effects of β1- and β2-adrenergic receptor block in long QT syndrome type 3: an in silico population study

Article References: Castelblanco Agostini, A. S., Miller, J. A., & Weinberg, S. H. (2026). Differential effects of β1- and β2-adrenergic receptor block in long QT syndrome type 3: an in silico population study. Frontiers in Physiology, 17, Article 1871155. https://doi.org/10.3389/fphys.2026.1871155

Image Credits: AI Generated

DOI: 10.3389/fphys.2026.1871155

Keywords: Long QT syndrome type 3, cardiac electrophysiology, computational modeling, beta-adrenergic signaling, ventricular myocytes, action potential duration, early afterdepolarizations, Differential, effects, adrenergic, receptor, block